Siegel, Michael P., Kruse, Shane E., Knowels, Gary, Salmon, Adam, Beyer, Richard, Xie, Hui, Van Remmen, Holly, Smith, Steven R., Marcinek, David J.
funding text
This work was supported by a New Scholar Award in Aging from The Ellison Medical Foundation (http://www.ellisonfoundation.org/), NIH grants AG022385, AG036606, AG028455 and AG030226, and NORC Center Grant DK072476. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
abstract
Oxidative stress and mitochondrial function are at the core of many degenerative conditions. However, the interaction between oxidative stress and in vivo mitochondrial function is unclear. We used both pharmacological (2 week paraquat (PQ) treatment of wild type mice) and transgenic (mice lacking Cu, Zn-superoxide dismutase (SOD1(-/-))) models to test the effect of oxidative stress on in vivo mitochondrial function in skeletal muscle. Magnetic resonance and optical spectroscopy were used to measure mitochondrial ATP and oxygen fluxes and cell energetic state. In both models of oxidative stress, coupling of oxidative phosphorylation was significantly lower (lower P/O) at rest in vivo in skeletal muscle and was dose-dependent in the PQ model. Despite this reduction in efficiency, in vivo mitochondrial phosphorylation capacity (ATPmax) was maintained in both models, and ex vivo mitochondrial respiration in permeabilized muscle fibers was unchanged following PQ treatment. In association with the reduced P/O, PQ treatment led to a dose-dependent reduction in PCr/ATP ratio and increased phosphorylation of AMPK. These results indicate that oxidative stress uncouples oxidative phosphorylation in vivo and results in energetic stress in the absence of defects in the mitochondrial electron transport chain.